Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing
FEATURED PRESENTERS
Yury Monczak, Ph.D / Ryan J. Schmidt, MD, PhD
- PRODUCTS
- CLINICAL LAB SERVICES
- DISEASES
Lymphoma
Lymphoma is a cancer that starts in cells that are part of the body’s immune system. Knowing which type of lymphoma you have is important because it affects your treatment options and your outlook (prognosis).
Myeloma
Multiple myeloma is a cancer of plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system.
- EXPLORE MENU ⟶
Browse our comprehensive menu of product & testing services.
- PARTNERSHIPS
- SCIENCE
- PUBLICATIONS
- NEWSROOM
- CAREERS
- COMPANY
Home/Videos/2020 Videos/Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing
- PRODUCTS
- CLINICAL LAB SERVICES
- DISEASES
- PARTNERSHIPS
- SCIENCE
- PUBLICATIONS
- NEWSROOM
- CAREERS
- COMPANY